Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...

A new study has found that generic drugs manufactured in India are linked to significantly more severe adverse events — including hospitalization, disability and in some cases death — compared to ...

Generics a Commonsense Answer to High Drug Prices ...

"If we can't solve this problem, it's only a matter of time" before lives are lost ...

The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on ...

Prescription drug prices in the United States remain a major financial burden for millions of Americans. As healthcare costs rise and insurance coverage becomes increasingly complex, patients are ...

Generic medications are not the same as brand medications. Small differences in ingredients that are permitted by the FDA may ...

Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

The EU has been pushing for a six to 10 years’ data exclusivity period, which would prevent India from using an innovator's ...

The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.

The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...